Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Oncology |
Investing | United States |
Militia Hill Ventures is a Venture Capital Fund specializing in Equity investments within the life sciences sector. Founded in 2013 and headquartered at 3001 Market St, Suite 140, Philadelphia, Pennsylvania, 19104, United States, the firm has cemented its role in advancing the BioTech, HealthTech (& Fitness), Medical Devices (& Hospital Services), and Oncology industries in the Philadelphia region. They operate with a mission to create and develop exceptional life sciences companies. Their investment thesis revolves around accelerating life science innovations by harnessing their broad network, relationships, and domain expertise. They catalyze premier science and proven management alongside successful life sciences investors to birth high-quality, fast-growing companies. Militia Hill Ventures employs an active build approach, which they believe is the most effective strategy in fostering great companies that can produce new life-saving therapies for patients and generate high-value returns for their investors. By providing select portfolio companies and teams with preferred access to an abundance of resources—including expertise, capital, relationships, and infrastructure—they aim to increase the number of high-quality life sciences businesses and products in the greater Philadelphia area. Their approach not only seeks to maximize investor returns but also to expedite the development of products that save lives. Militia Hill Ventures is intent on expanding the life sciences ecosystem and achieving outcomes that benefit both the industry and patients in need of innovative treatments.